News

Beat the Market the Zacks Way: FirstEnergy, Seanergy Maritime, Amgen in Focus

JNJ, FE, VIV, FAST, AMGN, CHD, MPWR, LNG, VIRT, SHIP, NOBL, ROKU

FirstEnergy gains 10.3% post-upgrade as Zacks highlights standout performers like Seanergy Maritime and Amgen amid a volatile but rising market.

OpenAI touts Amazon alliance in memo, says Microsoft has 'limited our ability' to reach clients

AMZN, MSFD

In an internal memo, OpenAI's new revenue chief pointed to the artificial intelligence company's ongoing effort to reduce its reliance on Microsoft.

Buy These 5 Manufacturing Stocks to Tap Recent Industry Rally

FLS, NDSN, DXPE, GHM, GTES

DXPE, GHM, NDSN, GTES and FLS ride a manufacturing rebound as PMI growth and rising demand fuel momentum.

Astera Labs, Inc. (ALAB) Soars 15.1%: Is Further Upside Left in the Stock?

ALAB, RBRK

Astera Labs, Inc. (ALAB) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Strength Seen in Applied Optoelectronics (AAOI): Can Its 13.0% Jump Turn into More Strength?

AAOI, SVCO

Applied Optoelectronics (AAOI) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Here are Monday's biggest analyst calls: Nvidia, Apple, Tesla, CoreWeave, Blackstone, Starbucks, Netflix & more

CRWV, NVDACL, AAPL, NFLXCL, TSLACO, SBUX.USD

Here are the biggest calls on Wall Street on Monday.

Europe cheers Orbán defeat as a bloody nose for the Kremlin – but Hungary’s future remains contested

European leaders welcome the election of a pro-EU candidate while Russia and the U.S. lose an ally after the defeat of Viktor Orbán.

Roblox defends expanded age‑checks after parents raise concerns over errors

With 144m daily users, the gaming company is extending its tech to introduce two age‑specific accounts.

Will AbbVie's Neuroscience Franchise Aid Top-line Growth in Q1?

BIIB, JNJ, ABBV

ABBV eyes a strong Q1 performance as neuroscience sales, led by Botox and Vraylar, are set to jump 22%, with newer drugs helping offset declines in legacy treatments.

Strait of Hormuz blockade, Goldman Sachs earnings, AI cybersecurity and more in Morning Squawk

Here are five key things investors need to know to start the trading day.